Our results show that protein and mRNA of RIPK3 were expressed in HCT116 p53+/+ cells and in other colon cancer cells, findings supported by our experiments involving specific siRNAs and inhibitors (Figure 5 and Supplementary Figure 2). Here, TP53 is linked to colonic neoplasm.